A practical methodology for estimating the financial value of Clinician Retention Intelligence
Traditional ROI analyses often require organizations to wait years before enough actual resignations occur to determine whether a retention intervention worked. By then, the disruption to patient care and financial costs have already been realized. The Atalan Value Framework estimates value much earlier by measuring changes in validated resignation risk among clinicians receiving active intervention and comparing those changes with statistically similar clinicians who were not actively managed. This allows organizations to evaluate progress in months rather than years using a disciplined, comparison-based methodology.
Methodology
1. Establish the financial value of one clinician retained
Calculate your own, or published industry benchmarks:
- APP: approximately $250,000
- Physician: specialty-specific estimates beginning around $843,000
When calculating retention value include costs associated with:
- recruiting
- onboarding
- lost productivity
- vacancy
- temporary coverage
- downstream operational disruption
2. Compare similar clinicians
Clinicians who were actively managed using Atalan are matched to statistically similar clinicians who were not to better isolate the effect of active intervention.
Match with available variables including:
- specialty
- age
- baseline risk
- tenure trajectory
- market/location
3. Measure incremental improvement
Atalan measures changes in each clinician’s predicted resignation risk after leaders begin actively using the platform. Those changes are then compared with statistically similar clinicians who were not actively managed. The difference between those two groups represents the incremental improvement associated with active platform use. Only the incremental improvement beyond that observed in the matched comparison group is attributed to active platform engagement.
Example:
Control group: 22% improved
Intervention group: 38%
Incremental improvement: 16 percentage points
4. Convert incremental improvement into financial value
Active Clinicians × Incremental Improvement × Replacement Cost = Estimated retained value
Important: The Atalan Value Framework estimates the value associated with changes in resignation risk—not the precise number of resignations prevented. As additional longitudinal data becomes available, organizations can validate these estimates against observed turnover over time.
Observed Outcomes
This methodology has been applied to two early implementations with large health systems and has demonstrated consistent patterns:
- Observation periods: 6–9 months
- Clinical workforce actively managed: approximately 4–5%
- Incremental improvement over matched controls: 11–21 percentage points
- Estimated retained value: $7–8.5 million
Notably, these results were achieved while actively managing only a small fraction of the overall clinical workforce.
The “Dose Response” – greater engagement produced greater benefit
- repeated profile reviews produced larger improvements
- multiple stakeholders reviewing the same clinician produced the strongest outcomes
- highest-usage markets consistently showed the greatest improvement
Better implementation produces better outcomes
- structured deployment outperformed unstructured deployment
- markets with broader adoption consistently outperformed lighter users
- organizations with more consistent platform engagement and structured change management produced the strongest outcomes
FAQs
1. Why didn’t you just measure actual resignations?
Actual turnover takes years to accumulate.
This methodology measures changes in validated resignation risk and estimates financial value from those improvements.
Risk improvement allows organizations to evaluate interventions within months instead of waiting two to three years for resignation outcomes.
2. Correlation isn’t causation.
That’s true. The methodology estimates the financial value associated with active platform engagement. While matching strengthens the comparison, observational analyses cannot fully eliminate all sources of bias.
3. “Maybe leaders who use Atalan are simply better leaders.”
Leadership quality almost certainly influences retention outcomes. That’s one reason this methodology uses matched comparison groups rather than simple before-and-after measurements. While leadership quality cannot be completely separated from platform use, the consistent observation that greater engagement produces greater improvement strengthens confidence that the platform contributes meaningful value.
4. How do we know improvements in risk score are tied to actual reductions in future resignations?
Atalan continuously validates its predictive models against actual resignation outcomes and performs a historical “look-back” during each implementation to confirm that the model accurately ranks resignation risk before the platform is used operationally. Current implementations have demonstrated predictive performance exceeding 70% using Atalan’s internal validation methodology.